# Friedemann Paul

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/friedemann-paul/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50,643 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 111 |
| i10-index | 613 |
| Last Known Institution | Max Delbrück Center |
| OpenAlex ID | https://openalex.org/A5056912783 |
| ORCID iD | 0000-0002-6378-0070 |
| Works | 1,124 |

## Researcher papers

Showing 12 of 23.

- [Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria](https://scholariq.org/papers/diagnosis-of-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/)
- [MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome](https://scholariq.org/papers/mog-igg-in-nmo-and-related-disorders-a-multicenter-study-of-50-patients-part-2/)
- [Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients](https://scholariq.org/papers/contrasting-disease-patterns-in-seropositive-and-seronegative-neuromyelitis/)
- [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing](https://scholariq.org/papers/mog-encephalomyelitis-international-recommendations-on-diagnosis-and-antibody/)
- [Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial](https://scholariq.org/papers/inebilizumab-for-the-treatment-of-neuromyelitis-optica-spectrum-disorder-n/)
- [MRI characteristics of neuromyelitis optica spectrum disorder](https://scholariq.org/papers/mri-characteristics-of-neuromyelitis-optica-spectrum-disorder/)
- [Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)](https://scholariq.org/papers/update-on-the-diagnosis-and-treatment-of-neuromyelitis-optica-recommendations-of/)
- [Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis](https://scholariq.org/papers/retinal-layer-segmentation-in-multiple-sclerosis-a-systematic-review-and-meta/)
- [Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines](https://scholariq.org/papers/assessment-of-lesions-on-magnetic-resonance-imaging-in-multiple-sclerosis/)
- [Myelin-oligodendrocyte glycoprotein antibody-associated disease](https://scholariq.org/papers/myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/)
- [A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms](https://scholariq.org/papers/a-diet-mimicking-fasting-promotes-regeneration-and-reduces-autoimmunity-and/)
- [A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity](https://scholariq.org/papers/a-prospective-observational-study-of-post-covid-19-chronic-fatigue-syndrome/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [Autoimmune Neurological Disorders and Treatments](https://scholariq.org/topics/autoimmune-neurological-disorders-and-treatments/)

## Researcher university

- [Max Delbrück Center](https://scholariq.org/institutions/max-delbruck-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.